This study looks at whether a new treatment called sacituzumab tirumotecan, given alone or with pembrolizumab, can help people with triple-negative breast cancer. Researchers want to see if this combination helps people live longer or keeps the cancer from growing or spreading compared to standard chemotherapy.
The trial's ID is NCT06841354. It is a Phase 3 study, which means it is looking at how well the treatment works and how safe it is. The trial is regulated by the FDA, and it aims to include about 1,000 participants.
Who can join
Men and women aged 18 and older can join. Participants must have advanced triple-negative breast cancer that has not been treated before. Some health conditions may prevent joining, but the trial team will confirm eligibility.
Condition
Triple Negative Breast Neoplasms
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be placed into three groups by chance:
One group receives sacituzumab tirumotecan alone every two weeks.
Another group gets sacituzumab tirumotecan along with pembrolizumab.
The last group receives a chemotherapy treatment chosen by their doctor. Everyone will be monitored for how well the treatments work.
Where
This trial is enrolling at 38 locations. Recruiting sites are listed first.
AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007)
Altamonte Springs, Florida
Recruiting
Allina Health Cancer Institute ( Site 0069)
Minneapolis, Minnesota
Recruiting
Cancer & Hematology Centers of Western Michigan ( Site 0026)
Grand Rapids, Michigan
Recruiting
City of Hope ( Site 0097)
Duarte, California
Recruiting
City of Hope Lennar Foundation Cancer Center ( Site 0099)
Irvine, California
Recruiting
Comprehensive Cancer Centers of Nevada ( Site 0015)
Director of the Breast Cancer Center at NYU Langone’s Perlmutter Cancer Center. Treats breast cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Inaugural Jeffrey F. Moley Professor of Endocrine and Oncologic Surgery, WashU. Treats breast cancer. A surgeon is the doctor who removes cancer with an operation (adults). Recognized at state, national or international level.
Microsurgical breast reconstruction specialist, MSK. Treats breast cancer and mouth cancer. Offers microsurgical breast reconstruction, head and neck reconstruction and abdominal wall reconstruction.